It was Daniel.

Not in a family photo. Not at a wedding. In grainy surveillance footage, standing beside a black SUV outside a federal office building in Denver, Colorado.

My throat tightened. “What is this?”

“We’ve been investigating financial fraud connected to a biomedical startup,” Ortiz said. “Shell companies, stolen patient data, illegal testing contracts. Your son-in-law’s name surfaced six weeks ago.”